Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

OBJECTIVE: Increases in serum calcitonin, a tumor marker for medullary thyroid carcinoma (MTC), have been associated with glucagon-like peptide 1 receptor agonist use in some preclinical studies. We report calcitonin changes in exenatide-treated and placebo-administered participants and MTC incidenc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Bethel, M. Angelyn, Patel, Rishi A., Thompson, Vivian P., Merrill, Peter, Reed, Shelby D., Li, Yanhong, Ahmadi, Sara, Katona, Brian G., Gustavson, Stephanie M., Ohman, Peter, Iqbal, Nayyar, Gagel, Robert F., Hernandez, Adrian F., Buse, John B., Holman, Rury R.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2019
Matèries:
Emerging Therapies: Drugs and Regimens
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973544/
https://ncbi.nlm.nih.gov/pubmed/31010875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-2028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars